Moteur de recherche d’entreprises européennes
UK funding (179 400 £) : Ligniflex: A synthetic biology platform to optimise the process and products of enzymatic lignin disruption Ukri01/08/2013 UK Research and Innovation, Royaume Uni
Vue d’ensemble
Texte
Ligniflex: A synthetic biology platform to optimise the process and products of enzymatic lignin disruption
| Abstract | This project will develop new bioprocesses to convert lignin, one of the world’s largest natural by-products of lignocellulosic biomass and paper and pulp processing, to a sustainable source of high value chemical building blocks. It will also demonstrate feasibility to replace unsustainable petrochemical derived raw materials, currently used in the manufacture of chemicals, plastics and packaging. Proven, manipulable strains of industrial yeast will be engineered using methods of, combinatorial genetics, bioinformatics and synthetic biology to permit many hundreds of specific enzyme combinations to be tested for optimal lignin degradation. The project will demonstrate the potential for synthetic biology to construct and optimise industrial microbes suitable for economical, enzymatic degradation of lignin with characterisation of the resulting products as potential new raw materials for the chemical industries. |
| Category | Feasibility Studies |
| Reference | 131172 |
| Status | Closed |
| Funded period start | 01/08/2013 |
| Funded period end | 31/01/2015 |
| Funded value | £179 400,00 |
| Source | https://gtr.ukri.org/projects?ref=131172 |
Participating Organisations
| INGENZA LIMITED |
£179 400,00 |
| UNIVERSITY OF EDINBURGH |
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Ingenza Ltd., Edinburgh Technopole, Royaume Uni.
Les visualisations de "Ingenza Ltd. - UK funding (179 400 £) : Ligniflex: A synthetic biology platform to optimise the process and products of enzymatic lignin disruption"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
